BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 9627010)

  • 1. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage.
    Glant TT; Cs-Szabó G; Nagase H; Jacobs JJ; Mikecz K
    Arthritis Rheum; 1998 Jun; 41(6):1007-18. PubMed ID: 9627010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
    J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical roles of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation.
    Glant TT; Buzás EI; Finnegan A; Negroiu G; Cs-Szabó G; Mikecz K
    J Immunol; 1998 Apr; 160(8):3812-9. PubMed ID: 9558085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis.
    Glant TT; Mikecz K
    Methods Mol Med; 2004; 102():313-38. PubMed ID: 15286393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background.
    Szántó S; Bárdos T; Szabó Z; David CS; Buzás EI; Mikecz K; Glant TT
    Arthritis Rheum; 2004 Jun; 50(6):1984-95. PubMed ID: 15188376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of arthritis in SCID mice by T cells specific for the "shared epitope" sequence in the G3 domain of human cartilage proteoglycan.
    Hanyecz A; Bárdos T; Berlo SE; Buzás E; Nesterovitch AB; Mikecz K; Glant TT
    Arthritis Rheum; 2003 Oct; 48(10):2959-73. PubMed ID: 14558103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
    Berlo SE; Guichelaar T; Ten Brink CB; van Kooten PJ; Hauet-Broeren F; Ludanyi K; van Eden W; Broeren CP; Glant TT
    Arthritis Rheum; 2006 Aug; 54(8):2423-33. PubMed ID: 16869010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity.
    van Meurs J; van Lent P; Stoop R; Holthuysen A; Singer I; Bayne E; Mudgett J; Poole R; Billinghurst C; van der Kraan P; Buma P; van den Berg W
    Arthritis Rheum; 1999 Oct; 42(10):2074-84. PubMed ID: 10524678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate.
    Guerassimov A; Zhang Y; Banerjee S; Cartman A; Leroux JY; Rosenberg LC; Esdaile J; Fitzcharles MA; Poole AR
    Arthritis Rheum; 1998 Jun; 41(6):1019-25. PubMed ID: 9627011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
    Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and aggrecanases cleave aggrecan in different zones of normal cartilage but colocalize in the development of osteoarthritic lesions in STR/ort mice.
    Chambers MG; Cox L; Chong L; Suri N; Cover P; Bayliss MT; Mason RM
    Arthritis Rheum; 2001 Jun; 44(6):1455-65. PubMed ID: 11407708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to cartilage link protein and the G1 domain of proteoglycan aggrecan in patients with osteoarthritis.
    Guerassimov A; Zhang Y; Cartman A; Rosenberg LC; Esdaile J; Fitzcharles MA; Poole AR
    Arthritis Rheum; 1999 Mar; 42(3):527-33. PubMed ID: 10088776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
    Lohmander LS; Ionescu M; Jugessur H; Poole AR
    Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis.
    Singer II; Kawka DW; Bayne EK; Donatelli SA; Weidner JR; Williams HR; Ayala JM; Mumford RA; Lark MW; Glant TT
    J Clin Invest; 1995 May; 95(5):2178-86. PubMed ID: 7537757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of fibronectin neoepitopes present in human osteoarthritic cartilage.
    Zack MD; Arner EC; Anglin CP; Alston JT; Malfait AM; Tortorella MD
    Arthritis Rheum; 2006 Sep; 54(9):2912-22. PubMed ID: 16948117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
    Squires GR; Okouneff S; Ionescu M; Poole AR
    Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB/c mice.
    Buzás EI; Brennan FR; Mikecz K; Garzó M; Negroiu G; Holló K; Cs-Szabó G; Pintye E; Glant TT
    J Immunol; 1995 Sep; 155(5):2679-87. PubMed ID: 7544381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
    Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
    Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.